Human Tick-Borne Encephalitis Virus plus IgG ELISA Kit (TBE/FSME)
Be the first to review this product! Submit a review
|
(0 Publication)
- Colorimetric readout - 450 nm - Works on any standard plate reader
- Easy results interpretation
- Cut-off, positive and negative controls included
Reactivity data
Product details
Abcam's anti-Tick-borne encephalitis (TBE) virus IgG plus Human in vitro ELISA (Enzyme-Linked Immunosorbent Assay) kit is designed for the accurate quantitative measurement of IgG class antibodies against Tick-borne encephalitis virus in Human serum and plasma.
A 96-well plate has been precoated with Tick-borne encephalitis antigens to bind cognate antibodies. Controls or test samples are added to the wells and incubated. Following washing, a horseradish peroxidase (HRP) labelled anti-Human IgG conjugate is added to the wells, which binds to the immobilized Tick-borne encephalitis-specific antibodies. TMB is then catalyzed by the HRP to produce a blue color product that changes to yellow after adding an acidic stop solution. The density of yellow coloration is directly proportional to the amount of Tick-borne encephalitis IgG sample captured in plate.
Precision
What's included?
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The Tick-Borne Encephalitis virus interacts with the immune system through the production of specific antibodies including IgG. These antibodies form part of the host's immune response targeting viral antigens to neutralize infection. The virus itself however does not belong to a larger protein complex but its structural proteins enable interaction with host immune cells sparking antibody production detected using ELISA tests.
Pathways
Viral entry and replication of the Tick-Borne Encephalitis virus engage with signal transduction and immune response pathways. The interferon signaling pathway becomes activated when the virus enters the host facilitating an antiviral state within infected cells. In this context the virus interacts with proteins such as IFN-alpha and IFN-beta influencing the host's antiviral defenses.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
- Download websiteProtocolBooklet|en
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com